Indogulf Cropsciences Ltd IPO

The company is subject to regular inspections and audits, and the success and wide acceptability of its products is largely dependent upon the company quality controls and standards. Any failures to comply with quality standards may adversely affect its business prospects and financial performance, including cancellation of existing and future orders which may expose it to warranty claims.

The value of its brands may be diluted if there is a change in the brand name for a known product, quality concern, negative publicity which could adversely affect its business, financial condition and results of operations.

Its historical cumulative average growth rate ("CAGR") in Revenue from Operations, EBITDA and PAT, may not be indicative of its future performance.

Under-utilization of its manufacturing capacities and an inability to effectively utilize the company expanded manufacturing capacities could have an adverse effect on its business, future prospects and future financial performance.

Its inability to collect receivables and default in payment from the company customers could result in the reduction of its profits and affect the company cash flows.

Any shortfall in the supply of its components and raw materials or an increase in the company component or raw material costs, or other input costs, may adversely affect the pricing and supply of its products and have an adverse effect on the company business, results of operations and financial condition.

The company intend to deploy a substantial portion of the Net Proceeds aggregating to Rs. 650.00 million towards funding its working capital requirements, which is based on certain assumptions. Any change in working capital requirements on account of such assumptions may materially adversely affect its results of operations and profitability.

The agrochemicals industry is capital intensive, and its may need to seek additional financing in the future to support the company growth strategies. Any failures to raise additional financing could have an adverse effect on its business, results of operations, financial condition and cash flows.

The Offer Price, price to earnings ratio and market capitalization to revenue multiple based on the Offer Price of the Company, may not be indicative of the market price of the Company on listing or thereafter.

The determination of the Price Band is based on various factors and assumptions, and the Offer Price of its Equity Shares may not be indicative of the market price of its Equity Shares after the Offer.